National Instruments (Nasdaq: NATI) today announced the new NI cRIO-9068 software-designed controller, which is completely redesigned but maintains full NI LabVIEW and I/O compatibility with the CompactRIO platform. The controller integrates state-of-the-art technologies including the Xilinx Zynq-7020 All Programmable system on a chip (SoC), which combines a dual-core ARM® Cortex™-A9 processor and Xilinx 7 Series FPGA fabric.
To view Multimedia News Release, go to http://www.multivu.com/mnr/62759-national-instruments-redesigns-ni-compactrio-software-controller-platform
Isle of Capri Casinos, Inc. (NASDAQ: ISLE) and Nemacolin Woodlands Resort announced today that Lady Luck Casino Nemacolin opened to the public at noon today to enthusiastic crowds. Lady Luck Casino Nemacolin, which is located approximately 70 miles south of Pittsburgh, created over 350 construction jobs, received approximately 2500 job applications and hired over 500 employees.
To view the Multimedia News Release, go to http://www.multivu.com/mnr/62069-isle-of-capri-casinos-lady-luck-casino-nemacolin-opens
Seattle’s Best Coffee, together with innovative food manufacturer Inventure Foods, Inc. (NASDAQ:SNAK)—the company responsible for bringing the “at home” frozen smoothie category to life in grocery store freezers three years ago—today unveiled Seattle’s Best Coffee® Frozen Coffee Blends, available in grocery, club and mass merchandise stores nationwide. Part of Starbucks corporation (NASDAQ: SBUX), Seattle’s Best brings great coffee to new and unexpected places. The blended coffee drink category continues to grow, with U.S. sales surging to $4.3 billion last year[1].
To view the Multimedia News Release, go to http://www.multivu.com/mnr/62097-seattle-s-best-coffee-frozen-coffee-blends-at-home-frozen-smoothie
OpenText™ (NASDAQ: OTEX, TSX: OTC), the global leader in Enterprise Information Management (EIM), today unveiled OpenText Web Experience Management (WEM), an innovative solution to help organizations exceed their customers’ online expectations by providing a targeted, responsive experience across omni-channel touch points, multiple languages and devices with varied capabilities and form-factors.
To view the Multimedia News Release, go to http://www.multivu.com/mnr/61775-opentext-web-experience-management-engage-your-web-traffic
Jive Software, Inc. (Nasdaq:JIVE), rolled out today the latest version of Producteev by Jive, the leading social task management solution that allows individuals, teams, and now entire organizations to easily track and manage tasks for free – regardless of how many people within a team or organization use the application and an approach that no other task management app on the market can match today. The new version of the product builds on the innovative foundation built by Producteev, which was acquired by Jive late last year, and provides companies with a more productive yet inexpensive way to get the fundamental components of work — tasks — organized and completed easily.
To view Multimedia News Release, go to http://www.multivu.com/mnr/61749-jive-software-producteev-task-management-more-conceptual-and-organized
Netflix, Inc. (Nasdaq: NFLX) has unveiled revealing, new information that confirms a sneaking suspicion— more than half (51%) of couples are likely to “cheat”1—but don’t start grilling your significant other or giving them the evil eye just yet.
A recent survey conducted by Harris Interactive on behalf of Netflix2 revealed 51% of those in a relationship would “cheat” on their spouse/partner/significant other by streaming a TV program(s) they agreed to watch together before their partner had a chance to watch it. More specifically, more than 28 million3 U.S. adults (12%) confessed they had already cheated and 10% admitted they had been “cheated on4.” It seems as though sometimes that next episode of your favorite series is just too tempting to wait for your partner. Sneaking around with that addictive little show may seem like a minor form of infidelity—but don’t be surprised if it leads to a few slamming doors and a bit of the silent treatment.
To view Multimedia News Release, go to http://www.multivu.com/mnr/61735-netflix-survey-more-than-half-of-couples-consider-stream-cheating
In recognition of Melanoma Monday® and National Melanoma/Skin Cancer Detection & Prevention MonthTM, MELA Sciences, Inc. (NASDAQ: MELA) visited the NASDAQ MarketSite in Times Square today to ring the Opening Bell and sponsor free skin cancer checks.
One American dies every hour from melanoma, the most deadly skin cancer. MELA Sciences, Inc. is the pioneer company behind MelaFind®, the first and only FDA-approved diagnostic tool that helps dermatologists detect melanoma at its most curable stage. MelaFind® was approved by the U.S. Food & Drug Administration (FDA) in Fall 2011, and since then has strategically rolled out the technology to dermatology practices across the country.
To view Multimedia News Release, go to http://www.multivu.com/mnr/61584-mela-sciences-rings-opening-bell-awareness-melanoma-detection-prevention
Destination XL Group, Inc. (NASDAQ: DXLG), the leading retailer of men’s XL apparel and accessories, launched a new national advertising campaign designed to draw attention to the many challenges men who wear XL sizes face when shopping for clothes and position Destination XL (DXL) as the one-stop-shopping solution for the style needs of this underserved consumer.
The TV and radio spots, titled “No Man’s Land”, use humor to underscore the shared and relatable shopping frustrations bigger guys face, and remind them that Destination XL is committed to addressing their fashion needs.
To view Multimedia News Release, go to http://www.multivu.com/mnr/61481-destination-xl-national-ad-campaign-to-support-major-retail-expansion
Raptor Pharmaceutical Corp. (“Raptor” or the “Company”) (Nasdaq: RPTP), today announced that the U.S. Food and Drug Administration (FDA) has approved PROCYSBI™ (cysteamine bitartrate) delayed release capsules for the treatment of nephropathic cystinosis in adults and children 6 years and older. In a Phase 3 study, PROCYSBI showed consistent cystine depletion over the full 12-hour dosing period. Sustained levels of cysteamine have not historically been achieved in the majority of patients in this population. Studies have shown that sustained cystine depletion in patients may significantly delay disease progression, including kidney dysfunction, dialysis, kidney transplant, organ failure and premature death.
To view Multimedia News Release, go to http://www.multivu.com/mnr/61338-raptor-pharmaceutical-procysbi-fda-approval-nephropathic-cystinosis
Solta Medical, Inc. (Nasdaq: SLTM), the global market leader in aesthetic skin treatments, today announced the launch of the Simply Smart Rewards Program for Clear + Brilliant laser treatments, the first-ever patient loyalty program in aesthetic laser skin resurfacing.
Clear + Brilliant and Clear + Brilliant Perméa treatments have been shown to help improve skin tone, texture and other subtle signs of aging. The precise laser energy has allowed most consumers to experience immediate and progressive results that last for months, but vary by age, skin condition and how they protect their skin. The treatment takes about 20 minutes, is safe for all skin types and is suitable for men and women.
To view Multimedia News Release, go to http://www.multivu.com/mnr/61178-solta-medical-launches-clear-brilliant-simply-smart-rewards-program
WebMD Health Corp. (Nasdaq: WBMD), the leading source of health information, announced today the launch of the WebMD Pregnancy app, a free iPhone® app offering expectant moms WebMD’s physician-reviewed pregnancy information that is customizable to fit a woman’s unique pregnancy. The WebMD Pregnancy App is WebMD’s latest addition to its multi-screen platform approach which provides actionable health information when consumers want it most, enabling them to better manage their health. WebMD is the leader in mobile for health information, with WebMD’s mobile apps for consumers having been downloaded over 16 million times.1
To view Multimedia News Release, go to http://www.multivu.com/mnr/60045-webmd-launches-new-pregnancy-app-for-iphone
1appFigures data through December 26, 2012; includes WebMD App, WebMD Baby App, WebMD Pain Coach App
WebMD Health Corp. (Nasdaq: WBMD), the leading source of health information, announced today its new WebMD Allergy app for the iPhone, an innovative new mobile resource that empowers consumers to take control of their allergies. It is the first free app to provide allergy sufferers with personalized location-based allergy condition forecasts in combination with WebMD’s trusted information and insights. WebMD Allergy is further personalized with optional mobile push notifications that warn when allergen levels are high, enabling app users to proactively manage their allergy conditions.
To view Multimedia News Release, go to http://www.multivu.com/mnr/60044-webmd-introduces-new-allergy-app-for-iphone
